Loading market data...
Latest News
22 Aug 2026, 03:02 AM

Biopharmaceutical major Symbiotec Pharmalab has announced its ₹1,757-crore initial public offering, with a price band set between ₹938 and ₹988 per share. Opening on August 24, 2026, the book-built issue comprises a fresh capital raise and an offer for sale, targeting debt repayment and strengthened global manufacturing expansion.


USE THE NEWS

Scrip Price News % Change Change Time

*Disclaimer:* WOWNEWS24X7 is not a SEBI-registered advisor. Stocks mentioned are for info only, not investment advice.

Wow Stories
View All

Special News

View All

FOMO TO FMA - Dalal Street Wakes to Institutional Strength a...

21 Aug 2026, 07:41 AM

Global markets offered mixed cues, while Gift Nifty indicated a mildly positive domestic opening. Me...